Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 35.40 INR
Change Today +5.55 / 18.59%
Volume 397.8K
KILD On Other Exchanges
Symbol
Exchange
KILD is not on other exchanges.
As of 5:02 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

kilitch drugs (india) ltd (KILD) Snapshot

Open
30.70
Previous Close
29.85
Day High
35.80
Day Low
30.00
52 Week High
01/7/15 - 56.50
52 Week Low
05/16/14 - 19.20
Market Cap
468.4M
Average Volume 10 Days
16.6K
EPS TTM
-23.23
Shares Outstanding
13.2M
EX-Date
09/24/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KILITCH DRUGS (INDIA) LTD (KILD)

Related News

No related news articles were found.

kilitch drugs (india) ltd (KILD) Related Businessweek News

No Related Businessweek News Found

kilitch drugs (india) ltd (KILD) Details

Kilitch Drugs (India) Limited, a pharmaceutical company, manufactures and markets various formulations in solid, liquid, and parenteral dosage forms primarily in India. It manufactures antibacterial parenteral formulations and produces sterile liquid formulations. The company offers gastroenterology, anti-anginal, anti-convulsant, anti–inflammatory, anti-malarial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anaesthetic, neurotonic, epileptic, external preparation, veterinary, and contrast media products. Its products also include non steroidal anti inflammatory drugs; aminoglycosides; antibacterials; iron supplements for the treatment of anemia; uterine stimulants; local anesthetic products; and other products. In addition, the company provides contract manufacturing services to pharmaceutical companies. Kilitch Drugs (India) Limited also exports its products primarily to Benin, Togo, Burkina Faso, Mali, Niger, Ivory Coast, Tchad, Cameroon, Senegal, Rwanda, Gabon, Congo, Sudan, South Sudan, Namibia, South Africa, Zambia, Guinea Conakry, Nigeria, Mauritania, Papua New Guinea, Ethiopia, Sri Lanka, Cambodia, and Vietnam; and supplies products of various manufacturers. The company was incorporated in 1992 and is headquartered in Mumbai, India. Kilitch Drugs (India) Limited is a subsidiary of Kilitch Company Pharma Limited.

Founded in 1992

kilitch drugs (india) ltd (KILD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kilitch drugs (india) ltd (KILD) Key Developments

Kilitch Drugs (India) Limited, Board Meeting, Apr 27, 2015

Kilitch Drugs (India) Limited, Board Meeting, Apr 27, 2015. Agenda: To consider and approve the terms of settlement arrived at by the company with Aura Pharmaceuticals Inc.

Kilitch Drugs (India) Limited, Board Meeting, Apr 14, 2015

Kilitch Drugs (India) Limited, Board Meeting, Apr 14, 2015. Agenda: To consider conducting postal ballot of the company pursuant to Section 110 of the Companies Act, 2013 and rules prescribed thereunder and to finalize the notice of postal ballot for seeking shareholders approval pertaining to the appointment of Mr. Ramesh Modi as an independent director of the company; to consider appointment of Scrutinizer to oversee the postal ballot process of the company; and to consider delisting of the company’s securities from National Stock Exchange of India Limited.

Kilitch Drugs (India) Limited Management Appointments

Kilitch Drugs (India) Limited announced that as decided in the meeting of the Board of Directors of the company held on March 31, 2015, approved the appointment of Mr. Ramesh Modi as an independent Director of the company with effect from March 31, 2015 and Mr. C.K. Krishnan as the Chief Financial Officer (CFO) of the company with effect from March 31, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KILD:IN 35.40 INR +5.55

KILD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KILD.
View Industry Companies
 

Industry Analysis

KILD

Industry Average

Valuation KILD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 0.3x
Price/Cash Flow 29.1x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KILITCH DRUGS (INDIA) LTD, please visit www.kilitch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.